7% Off
Exelon Patch 109.5 mg/24
Novartis (Bangladesh) Ltd.
৳6249.60
Out Of Stock
Generic medicine
Rivastigmine Tartrate: Brands, Price & Uses in Bangladesh
Rivastigmine Tartrate is a cholinesterase inhibitor indicated for the treatment of the following conditions: Established / FDA-approved uses Mild to moderate dementia of the Alzheimer's type (oral…
About Rivastigmine Tartrate
Indications of Rivastigmine Tartrate
Rivastigmine Tartrate is a cholinesterase inhibitor indicated for the treatment of the following conditions:
Established / FDA-approved uses
- Mild to moderate dementia of the Alzheimer's type (oral capsule, oral solution, and transdermal patch formulations).
- Mild to moderate dementia associated with Parkinson's disease (oral capsule, oral solution, and transdermal patch formulations).
Not established / off-label
Rivastigmine Tartrate is not approved for severe Alzheimer's disease, vascular dementia, or other forms of cognitive impairment; use in these settings is not supported by robust evidence and is not recommended outside of specialist guidance.
Dosage & Administration of Rivastigmine Tartrate
The following describes the recommended dosing and titration schedule for Rivastigmine Tartrate in its oral and transdermal patch formulations.
Oral (capsules / oral solution)
| Step | Dose | Notes |
|---|---|---|
| Starting dose | 1.5 mg twice daily | Taken with meals (morning and evening) |
| Titration | Increase by 1.5 mg twice daily | At intervals of at least 2 weeks, based on tolerability |
| Usual maintenance range | 3 mg to 6 mg twice daily | Individualize to lowest effective, tolerated dose |
| Maximum dose | 6 mg twice daily (12 mg/day) | Do not exceed |
Transdermal patch
| Step | Dose | Notes |
|---|---|---|
| Starting dose | 4.6 mg/24 hours | Apply one patch daily |
| Titration | Increase to 9.5 mg/24 hours | After a minimum of 4 weeks, if well tolerated |
| Further titration (Alzheimer's disease only, if needed) | Up to 13.3 mg/24 hours | After a minimum of 4 weeks on 9.5 mg/24 hours, if additional benefit is needed and the dose is tolerated |
Administration: Apply the patch once daily to clean, dry, hairless, intact skin on the upper or lower back, upper arm, or chest; press firmly for about 30 seconds. Rotate application sites and do not reapply to the same site within 14 days. Remove the previous patch before applying a new one and never wear more than one patch at a time to avoid overdose. Avoid exposing the patch to external heat sources (heating pads, direct sunlight, sauna) as this may increase drug absorption.
If treatment with either the oral or transdermal formulation is interrupted for more than a few days, therapy should be restarted at the lowest dose and re-titrated to reduce the risk of severe gastrointestinal adverse effects; do not resume at the previously tolerated dose without medical guidance.
Side Effects of Rivastigmine Tartrate
The most commonly reported adverse effects of Rivastigmine Tartrate are gastrointestinal and are more frequent with oral dosing and during dose titration:
- Very common: Nausea, vomiting, diarrhea, decreased appetite, and weight loss (can be clinically significant, particularly in patients with low body weight).
- Common: Dizziness, headache, abdominal pain, dyspepsia, fatigue, asthenia, insomnia, anxiety, tremor.
- With the transdermal patch: Application-site reactions such as erythema, itching, or dermatitis are common; severe or spreading skin reactions should prompt discontinuation and medical evaluation.
- Less common but clinically important: Bradycardia and other cardiac conduction effects, syncope, extrapyramidal symptoms (worsening of Parkinsonian symptoms), and rarely, seizures or severe cholinergic reactions.
Gastrointestinal effects are dose-related and can usually be minimized with slow titration and administration with food; persistent vomiting or signs of dehydration warrant prompt medical attention.
Contraindications of Rivastigmine Tartrate
Rivastigmine Tartrate is contraindicated in patients with:
- Known hypersensitivity to rivastigmine, other carbamate derivatives, or any component of the formulation.
- A history of application-site reactions suggestive of allergic contact dermatitis to the Rivastigmine Tartrate transdermal patch (applies to the patch formulation).
Frequently Asked Questions about Rivastigmine Tartrate
What is Rivastigmine Tartrate used for?
Rivastigmine Tartrate is used to treat mild to moderate dementia caused by Alzheimer's disease and mild to moderate dementia associated with Parkinson's disease. It helps improve memory, thinking, and daily functioning in some patients, though it does not cure the underlying disease.
How should I take Rivastigmine Tartrate?
Oral capsules or solution should be taken twice daily with food (breakfast and dinner) to reduce nausea. The transdermal patch is applied once daily to clean, dry, hairless skin on the back, upper arm, or chest, with the application site rotated each day. Always follow your physician's specific dosing instructions.
What are the most common side effects of Rivastigmine Tartrate?
The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, loss of appetite, and weight loss. These are more common with oral dosing and during the early titration period, and often improve with slower dose increases and food. The transdermal patch can cause skin redness or irritation at the application site.
Can I use two Rivastigmine Tartrate patches at once if I miss a dose?
No. Never wear more than one Rivastigmine Tartrate patch at a time. Always remove the previous day's patch before applying a new one, as wearing multiple patches can cause a dangerous overdose. If you miss a dose, consult your physician or pharmacist rather than doubling up.
Is Rivastigmine Tartrate safe for the heart?
Rivastigmine Tartrate should be used with caution in patients with sick sinus syndrome or other cardiac conduction abnormalities, as it can slow the heart rate (bradycardia). Tell your doctor about any history of heart rhythm problems before starting Rivastigmine Tartrate.
What should I do if I stop Rivastigmine Tartrate for several days?
If treatment with Rivastigmine Tartrate is interrupted for more than a few days, do not resume at your previous dose. Contact your physician, who will typically restart you at the lowest dose and re-titrate upward gradually, since resuming at a higher dose after a break can cause severe nausea and vomiting.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.